Infectious disease research ‘alarmingly low’
Inside a pharmacy in India. The COVID-19 pandemic has raised questions about equal access to medicines. Copyright: Trinity Care Foundation, (CC BY-NC-ND 2.0). This image has been cropped.
Speed read
Focus on COVID-19 threatens to further divert attention
‘Half of key medicines’ are missing from equitable access plans
Share this article:
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
You have to credit our authors.
You have to credit SciDev.Net where possible include our logo with a link back to the original article.
New Oxford research institute established to tackle antimicrobial resistance pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
»UK Targets 24/7 Covid Vaccinations To Speed Rollout as PM Johnson Steps up Protection for At-risk Groups
1-MIN READ
UK Targets 24/7 Covid Vaccinations To Speed Rollout as PM Johnson Steps up Protection for At-risk Groups
For Representation.
Johnson hopes that giving protection to the elderly, the vulnerable and frontline workers by mid-February will provide a route out of a new national lockdown which began in England last week.
FOLLOW US ON:
Britain is targeting a 24-hour, seven-day a week vaccination programme as soon as possible, Prime Minister Boris Johnson said on Wednesday, as he bids to step up the pace of the rollout and give shots to at-risk groups by mid-February.
Britain is targeting a 24-hour, 7-day a week COVID-19 vaccination programme as soon as possible, Prime Minister Boris Johnson said on Wednesday, as he bids to step up the pace of the rollout with daily coronavirus deaths at record levels.
The pharmaceutical industry has urged countries to stick to the stated gap between COVID-19 vaccine doses and said any delay to the second injection should be based on science.
Some countries are putting back the second jab of vaccines that require two doses in order to maximise the number of people given some degree of protection through a first injection.
But in a joint statement by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the US and European federations and others, the industry said it supported adhering to the dosing studied in clinical trials.
They also said that sticking to the science would help combat scepticism over COVID-19 vaccines, and ultimately end the coronavirus crisis.